作者: Iris Schrijver , Nazneen Aziz , Daniel H. Farkas , Manohar Furtado , Andrea Ferreira Gonzalez
DOI: 10.1016/J.JMOLDX.2012.04.006
关键词:
摘要: This report of the Whole Genome Analysis group Association for Molecular Pathology illuminates opportunities and challenges associated with clinical diagnostic genome sequencing. With reality application next-generation sequencing, technical aspects molecular testing can be accomplished at greater speed higher volume, while much information is obtained. Although this a next logical step pathology laboratories, potential impact on process correlations extraordinary interpretation will challenging. We review rapidly evolving technologies; provide examples; discuss utility, ethics, consent; address analytic, postanalytic, professional implications.